➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Moodys
Colorcon
Medtronic
Merck

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Isoquinoline

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Isoquinoline?

Isoquinoline is an investigational drug.

There have been 11 clinical trials for Isoquinoline. The most recent clinical trial was a Phase 1 trial, which was initiated on July 1st 2018.

The most common disease conditions in clinical trials are Taeniasis, Neurocysticercosis, and Cysticercosis. The leading clinical trial sponsors are National Institute of Mental Health (NIMH), University of Washington, and Kenya Medical Research Institute.

There are three US patents protecting this investigational drug and forty-two international patents.

Recent Clinical Trials for Isoquinoline
TitleSponsorPhase
Comparation of Berberine and Metformin for the Treatment for MS in Schizophrenia PatientsTianjin Anding HospitalPhase 4
Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail ApproachNational Center for Complementary and Integrative Health (NCCIH)Early Phase 1
Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail ApproachWashington State UniversityEarly Phase 1

See all Isoquinoline clinical trials

Clinical Trial Summary for Isoquinoline

Top disease conditions for Isoquinoline
Top clinical trial sponsors for Isoquinoline

See all Isoquinoline clinical trials

US Patents for Isoquinoline

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Isoquinoline   Start Trial Materials for organic electroluminescent devices Merck Patent GmbH (DE)   Start Trial
Isoquinoline   Start Trial Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (Ewing, NJ)   Start Trial
Isoquinoline   Start Trial Compositions and methods for treating Dengue virus infection The J. David Gladstone Institutes (San Francisco, CA) The Regents of the University of California (Oakland, CA)   Start Trial
Isoquinoline   Start Trial Quinazolinone and isoquinolinone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (Tokyo, JP)   Start Trial
Isoquinoline   Start Trial Protein kinase C inhibitors and uses thereof Rigel Pharmaceuticals, Inc. (South San Francisco, CA)   Start Trial
Isoquinoline   Start Trial Highly conductive polymer film compositions from nanoparticle induced phase segregation of counterion templates from conducting polymers THE UNIVERSITY OF CONNECTICUT (Farmington, CT)   Start Trial
Isoquinoline   Start Trial Materials for organic light emitting diode UNIVERSAL DISPLAY CORPORATION (Ewing, NJ)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Isoquinoline

Drugname Country Document Number Estimated Expiration Related US Patent
Isoquinoline China 105916963 2034-01-17   Start Trial
Isoquinoline European Patent Office 3094703 2034-01-17   Start Trial
Isoquinoline Japan 2017508728 2034-01-17   Start Trial
Isoquinoline South Korea 20160103144 2034-01-17   Start Trial
Isoquinoline World Intellectual Property Organization (WIPO) 2015106789 2034-01-17   Start Trial
Isoquinoline China 104844658 2034-02-18   Start Trial
Isoquinoline European Patent Office 2907820 2034-02-18   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Moodys
Colorcon
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.